Suchergebnisse - "Anderson, Colleen"

PubPharm (7)

1

Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate

enthalten in: European child & adolescent psychiatry | 2016

von Nagy, P. | Häge, A. | Coghill, D. | +5

2

Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder

enthalten in: CNS drugs | 2014

von Dittmann, R. | Cardo, E. | Nagy, P. | +6

3

Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder : randomized-withdrawal study design

enthalten in: Journal of the American Academy of Child and Adolescent Psychiatry | 2014

von Coghill, D. | Banaschewski, T. | Lecendreux, M. | +9

4

Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder

enthalten in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2014

von Madhoo, M. | Keefe, R. | Roth, R. | +5

5

Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder : a head-to-head, randomized, double-blind, phase IIIb study

enthalten in: CNS drugs | 2013

von Dittmann, R. | Cardo, E. | Nagy, P. | +8

CommentIn: Expert Opin Pharmacother. 2014 Sep;15(13):1961-5. - PMID 25085429

6

European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

enthalten in: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology | 2013

von Coghill, D. | Banaschewski, T. | Lecendreux, M. | +8

7

A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents

enthalten in: CNS drugs | 2013

von Soutullo, C. | Banaschewski, T. | Lecendreux, M. | +8

1
[1]